Clinical Trial Update: Valacyclovir to Prevent Vertical Transmission of Cytomegalovirus After Maternal Primary Infection During Pregnancy [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial evaluating valacyclovir to prevent vertical transmission of cytomegalovirus after maternal primary infection during pregnancy has completed pha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Cytomegalovirus Infection

Drugs mentioned

• Valacyclovir (Valacyclovir)

Snippet

Sponsor: Rabin Medical Center | Conditions: Congenital Cytomegalovirus Infection | Phase 2, Phase 3 | Status: COMPLETED